Building a £1bn funds business
Graham Bentley, a non-executive director at Marlborough International, talks about active investing, Brexit and the company’s plans for building a £1bn (€1.12bn, $1.32bn) business.
Graham Bentley, a non-executive director at Marlborough International, talks about active investing, Brexit and the company’s plans for building a £1bn (€1.12bn, $1.32bn) business.
PineBridge Investments has a new head of Switzerland and Austria, while Guernsey Finance has promoted its multilingual international business development director to deputy chief executive. Fidelity International has appointed a head of equity.
It is not good enough to get away with what amounts to a closet tracking portfolio with fees that would correspond more appropriately with an active approach, says Rod Guest, international sales manager for Marlborough International Investment.
International intermediaries’ platform Novia Global has launched a new integrated investment portal, which provides access to a panel of discretionary fund managers (DFMs).
From managing money to managing families, Graham Bentley, on behalf of Marlborough International Management, shares his views on the best practice for IFAs.
Marlborough International Management has appointed a trio of international sales managers to head the distribution of its range of offshore feeder funds across Europe and the Middle East.
Giles Hargreave is a tour de force in the small-cap sector, with the Marlborough Special Situations Fund returning a spectacular 1,856% under his stewardship. His current focus is firmly on home soil.
Marlborough International Management has today launched four Guernsey-domiciled feeder funds to provide expanded offshore access to its UK- and Europe-invested fund range.
Marlborough International Management is launching offshore feeder funds for two of its best performing funds, including its Giles Hargreave-managed Special Situations Fund.
ATSG Funds and Marlborough, a Guernsey-based trust company, have launched a low cost QROPS, after having trialled the product for 12 months.